These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 4138773

  • 1. General aspects of anti-arrhythmic treatment with aprindine.
    Kesteloot H.
    Acta Cardiol; 1974; Suppl 18():303-16. PubMed ID: 4138773
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of rhythm disorders with aprindine. Results in 86 patients].
    Besse P, Giraudel JL, Grosgogeat Y, Haiat R, Puech P, Saulnier JP.
    Acta Cardiol; 1974; Suppl 18():389-407. PubMed ID: 4138152
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical study of a new anti-arrhythmia agent: aprindine].
    Palma-Gamiz JL, Boedo C, Lopez-Pujol FJ, de Uria JS.
    Acta Cardiol; 1974; Suppl 18():361-8. PubMed ID: 4138640
    [No Abstract] [Full Text] [Related]

  • 4. Preliminary experience in the treatment of cardiac arrhythmias with aprindine.
    Bollen G, Enderle J.
    Acta Cardiol; 1974; Suppl 18():355-60. PubMed ID: 4138528
    [No Abstract] [Full Text] [Related]

  • 5. Long-term oral antiarrhythmic therapy with aprindine (AC 1802).
    Breithardt G, Gleichmann U, Seipel L, Loogen F.
    Acta Cardiol; 1974; Suppl 18():341-53. PubMed ID: 4138089
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of chronic ventricular dysrhythmias with a new drug: aprindine (AC 1802).
    Van Durme JP, Rousseau M, Mbuyamba P.
    Acta Cardiol; 1974; Suppl 18():335-40. PubMed ID: 4138863
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aprindine (AC 1802), a new anti-arrhythmic drug.
    Kesteloot H, Van Mieghem W, De Geest H.
    Acta Cardiol; 1973; 28(2):145-65. PubMed ID: 4121909
    [No Abstract] [Full Text] [Related]

  • 9. [Anti-arrhythmic efficacy of aprindine during the acute phase of myocardial infarct].
    Hagemeijer F, Janse C, Hugenholtz PG.
    Acta Cardiol; 1974; Suppl 18():409-21. PubMed ID: 4138502
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome.
    Zipes DP, Gaum WE, Foster PR, Rosen KM, Wu D, Amat-Y-Leon F, Noble RJ.
    Am J Cardiol; 1977 Oct; 40(4):586-96. PubMed ID: 910722
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic effectiveness and plasma levels of a new antidysrhythmic drug: aprindine.
    Van Durme JP, Rosseel T, Bogaert M.
    Acta Cardiol; 1974 Oct; Suppl 18():233-4. PubMed ID: 4138126
    [No Abstract] [Full Text] [Related]

  • 15. [What is safe in the therapy of tachycardic heart arrhythmias?].
    Wehr M, Noll B, Krappe J.
    Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980
    [No Abstract] [Full Text] [Related]

  • 16. [Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)].
    Acta Cardiol; 1974 Dec; Suppl 18():441-58. PubMed ID: 4138236
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of various antiarrhythmic drugs (Aprindine, ajmaline, verapamil, oxprenolol, orciprenaline) on functional properties of accessory A-V pathways.
    Neuss H, Schlepper M.
    Acta Cardiol; 1974 Dec; Suppl 18():279-88. PubMed ID: 4547643
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.